UBS Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-380
| Closed | -$6.25K | – | 10415 |
|
|
2023
Q4 | $6.25K | Hold |
380
| – | – | ﹤0.01% | 7716 |
|
|
2023
Q3 | $2.94K | Hold |
380
| – | – | ﹤0.01% | 7625 |
|
|
2023
Q2 | $1.98K | Hold |
380
| – | – | ﹤0.01% | 7823 |
|
|
2023
Q1 | $2.04K | Sell |
380
-1,304
| -77% | -$7.09K | ﹤0.01% | 8598 |
|
|
2022
Q4 | $6.23K | Buy |
1,684
+1,303
| +342% | +$5.76K | ﹤0.01% | 9062 |
|
|
2022
Q3 | $2K | Sell |
381
-5
| -1% | -$28 | ﹤0.01% | 9832 |
|
|
2022
Q2 | $2K | Sell |
386
-500
| -56% | -$2.82K | ﹤0.01% | 9680 |
|
|
2022
Q1 | $7K | Sell |
886
-968
| -52% | -$9.48K | ﹤0.01% | 8879 |
|
|
2021
Q4 | $25K | Buy |
1,854
+487
| +36% | +$8.05K | ﹤0.01% | 7602 |
|
|
2021
Q3 | $31K | Sell |
1,367
-3,844
| -74% | -$114K | ﹤0.01% | 6730 |
|
|
2021
Q2 | $229K | Sell |
5,211
-5,622
| -52% | -$313K | ﹤0.01% | 5248 |
|
|
2021
Q1 | $786K | Buy |
10,833
+10,210
| +1,639% | +$725K | ﹤0.01% | 4490 |
|
|
2020
Q4 | $27K | Buy |
623
+239
| +62% | +$10.7K | ﹤0.01% | 6729 |
|
|
2020
Q3 | $16K | Buy |
384
+2
| +0.5% | +$103 | ﹤0.01% | 6489 |
|
|
2020
Q2 | $23K | Buy |
382
+1
| +0.3% | +$92 | ﹤0.01% | 6475 |
|
|
2020
Q1 | $29K | Sell |
381
-37
| -9% | -$4.26K | ﹤0.01% | 6248 |
|
|
2019
Q4 | $57K | Sell |
418
-4
| -0.9% | -$486 | ﹤0.01% | 6283 |
|
|
2019
Q3 | $50K | Buy |
422
+23
| +6% | +$3.21K | ﹤0.01% | 6205 |
|
|
2019
Q2 | $56K | Buy |
399
+347
| +667% | +$60.9K | ﹤0.01% | 5821 |
|
|
2019
Q1 | $9K | Sell |
52
-72
| -58% | -$10.8K | ﹤0.01% | 6900 |
|
|
2018
Q4 | $19K | Buy |
+124
| New | +$18.5K | ﹤0.01% | 6846 |
|
UBS Group's ORTX Position: Q1 2024 in Review
UBS Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 380 shares — an estimated $6.25K sold.
UBS Group first reported a position in ORTX in Q4 2018 and held it in 21 quarters. The position peaked at $786K in Q1 2021. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.
- UBS Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
- UBS Group sold 380 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $6.25K.
- UBS Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 21 quarters.
- UBS Group's Orchard Therapeutics plc American Depositary Shares position peaked at $786K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.
Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.